3
Total deals
$1.3B
Total value
$649.5M
Avg deal
$847.0M
Largest
| # | Acquired | Date | Type | Status | Price | |
|---|---|---|---|---|---|---|
| 1 |
Celenex
Celenex is developing treatments for rare genetic diseases.
|
2018-09-20 | Acquisition | Complete | $452.0M | Deal → |
| 2 |
Scioderm
Scioderm, a clinical stage pharmaceutical company, develops topical products for…
|
2015-08-31 | Acquisition | Complete | $847.0M | Deal → |
| 3 |
Callidus Biopharma
Callidus Biopharma is a drug discovery company developing enzyme replacement the…
|
2013-11-01 | — | Complete | — | Deal → |